Cetera Advisor Networks LLC Tekla Life Sciences Investors Transaction History

Cetera Advisor Networks LLC

$0
Q1 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 12, 2022	SELL	$15.35 - $19.29 $206,718 - $259,778	-13,467 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$18.5 - $21.59 $249,139 - $290,752	13,467 New	13,467 $259,000
Q3 2020 Nov 13, 2020	SELL	$16.71 - $19.06 $79,790 - $91,011	-4,775 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$14.22 - $18.38 $67,900 - $87,764	4,775 New	4,775 $86,000

Others Institutions Holding HQL

# of Institutions

75

Shares Held

9.51M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$48.7 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$11 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.96 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.66 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.93 Million
0.14% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.